2026-10-28 04:20:00 UTC#525903newconfirmednews
Cybin Inc. stock news
Cybin Inc. stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire10 wire items
2026-10-21 04:20:00 UTC#490480newconfirmednews
Helus Pharma Inc. average analyst price target raised to $43.62, implying 299% upside
2026-10-08 11:37:58 UTC#431925newconfirmedpress release
Helus Pharma Inc. (HELP) to host investor presentation on October 21, 2026
2026-10-01 11:30:00 UTC#398176newconfirmedpress release
Cybin Inc. officially changes legal name to Helus Pharma Inc., ticker HELP remains unchanged
2026-09-22 21:02:54 UTC#351926newconfirmedpress release
Helus Pharma (HELP) reports annual shareholder meeting results and sets effective date for legal name change
2026-09-11 13:10:02 UTC#298816updateconfirmednews
Cybin Executive Chair Eric So and CGO Paul Glavine report $3.7M in combined open-market stock purchases
2026-09-10 10:30:01 UTC#291086newconfirmednews
Cybin CGO Paul Glavine and Executive Chair Eric So report combined $2.39M in open-market stock purchases
2026-08-18 11:33:20 UTC#189258newconfirmedpress release
Helus Pharma names Regina Donohue Chief People Officer and adds Dr. Suresh Durgam to Scientific Advisory Board
2026-08-14 13:15:50 UTC#178185duplicateconfirmednews
Cybin Inc. reports Q2 adjusted loss of C$1.26 per share, missing analyst consensus of C$1.17 loss
2026-08-14 11:31:16 UTC#177602newconfirmednews